Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report

被引：0
|
作者：
Mehmood, Faisal [1 ]
Touseef, Mumtaz [2 ]
Ashraf, Amna [2 ]
Rai, Izza Ali [3 ]
机构：
[1] Combined Mil Hosp, Dept Radiol, Lahore, Pakistan
[2] Combined Mil Hosp, Dept Med, Lahore, Pakistan
[3] Combined Mil Hosp, Dept Vasc Surg, Lahore, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2024年 / 74卷 / 12期
关键词：
Hereditary breast ovarian cancer; Breast cancer; Ovarian cancer; HBOC; BRCA; PALB2; Chemotherapy; Carboplatin; Paclitaxel; PREVALENCE; MUTATIONS;
D O I：
10.47391/JPMA.20059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The co-occurrence of primary breast cancer and primary ovarian cancer is an exceptional hereditary phenomenon and results from inherent mutations in critical genes like a unique case of hereditary breast-ovarian cancer syndrome (HBOC) reported in Combined Military Hospital, Lahore, Pakistan. It was marked by pathogenic variants in RAD51D, PALB2, CHEK1, and TP53 genes. Remarkably, the patient exhibited an outstanding response to the chemotherapy agents, Carboplatin and Paclitaxel. This dynamic treatment not only led to nearly complete remission of high-grade ovarian serous cancer but also triggered regression in grade-2 invasive ductal breast cancer after just a few rounds of chemotherapy. Consequently, what started as palliative care evolved into a curative triumph.
引用
收藏
页码：2184 / 2187
页数：4
相关论文
共 50 条
  • [21] Identification and Management of Women at High Risk for Hereditary Breast/Ovarian Cancer Syndrome
    Ozanne, Elissa M.
    Loberg, Andrea
    Hughes, Sherwood
    Lawrence, Christine
    Drohan, Brian
    Semine, Alan
    Jellinek, Michael
    Cronin, Claire
    Milham, Frederick
    Dowd, Dana
    Block, Caroline
    Lockhart, Deborah
    Sharko, John
    Grinstein, Georges
    Hughes, Kevin S.
    BREAST JOURNAL, 2009, 15 (02) : 155 - 162
  • [22] Tolerability of PLD/Oxaliplatin Regimen in Recurrent Ovarian Cancer Patients With Previous Fragility to Carboplatin/Paclitaxel Treatment
    Dalla Palma, Maurizia
    Lombardi, Giuseppe
    Donach, Martin E.
    Borgato, Lucia
    Zustovich, Fable
    Furini, Lara
    Nicoletto, Maria O.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 305 - 308
  • [23] A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
    Adachi, S
    Ogasawara, T
    Ito, K
    Koyama, M
    Nagano, T
    Suzuki, A
    Yamada, T
    Nakata, Y
    Ozawa, M
    ONCOLOGY REPORTS, 2001, 8 (02) : 285 - 288
  • [24] HBOC syndrome with an uncharacterized variant in the BRCA1 gene in a patient diagnosed with endometrial cancer after surgery for bilateral breast cancer: A case report
    Mabuchi, Yasushi
    Hamano, Yuta
    Minami, Sawako
    Ota, Nami
    Ino, Kazuhiko
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [25] Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment
    Zorn, Kristin K.
    ONCOLOGY-NEW YORK, 2010, 24 (08): : 738 - 740
  • [26] The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer
    Hoekstra, Anna V.
    Hurteau, Jean A.
    Kirschner, Carolyn V.
    Rodriguez, Gustavo C.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : 377 - 381
  • [27] Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report
    Murakami, Hikaru
    Fujiwara, Satoe
    Nishie, Ruri
    Ueda, Shoko
    Terada, Shinichi
    Yamada, Takashi
    Ohmichi, Masahide
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [28] Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer
    Gordon, Alan N.
    Teneriello, Michael
    Janicek, Mike F.
    Hines, Jeffrey
    Lim, Peter C.
    Chen, M. Dwight
    Vaccarello, Luis
    Homesley, Howard D.
    McMeekin, Scott
    Burkholder, Tiana L.
    Wang, Yanping
    Zhao, Luping
    Orlando, Mauro
    Obasaju, Coleman K.
    Gill, John F.
    Tai, Datchen F.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (03) : 479 - 485
  • [29] Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: A case report and review of the literature
    Jayakody S.
    Wright D.B.
    Chiong C.
    Liu M.
    Bouffler C.
    El-Khoury T.
    Journal of Medical Case Reports, 12 (1)
  • [30] Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
    Vicente, Rodrigo
    Costa, Diogo Alpuim
    Vitorino, Marina
    Mendes, Ana Duarte
    Santos, Catarina
    Fontes-Sousa, Mario
    CANCERS, 2022, 14 (19)
12345